Named Patient Program With Rotigotine Transdermal System
NCT01095484
·
clinicaltrials.gov ↗
COMPLETED
Status
520
Enrollment
INDUSTRY
Sponsor class
Conditions
Conditions for Which There is a Documented Medical Necessity to Receive Treatment With Rotigotine
Interventions
DRUG:
Rotigotine patch
Sponsor
UCB Pharma